Risk factor
Very high price volatility
Profitability factor
Greatly undervalued vs peers
About
Operating as a medical technology firm, Safe Orthopaedics SA specializes in the creation and global distribution of sterile implants and disposable surgical tools designed to address spinal fracture conditions. Its innovative product line includes SteriSpine PS, a comprehensive system for managing both spinal fractures and degenerative spine issues. Additionally, they provide SteriSpine VA, a versatile suite encompassing pre-packaged Kyphoplasty and Cement solutions. The portfolio further extends to SteriSpine LC, offering pre-assembled instrumentation for lumbar cages like Cedar and Elm, and SteriSpine CC, which provides similar ready-to-use instruments for cervical cages, exemplified by Walnut. Established in 2010, the company's main operations are based in Éragny-sur-Oise, France.
Company Valuation
Based on key historical and expected multiples, the stock is greatly undervalued relative to its peers.